PMID: 22568136May 10, 2012Paper

Anti-influenza virus agent

Nihon rinsho. Japanese journal of clinical medicine
Shigeki Nakamura, Shigeru Kohno

Abstract

The necessity of newly anti-influenza agents is increasing rapidly after the prevalence of pandemic influenza A (H1N1) 2009. In addition to the existing anti-influenza drugs, novel neuraminidase inhibitors such as peramivir (a first intravenous anti-influenza agent) and laninamivir (long acting inhaled anti-influenza agent) can be available. Moreover favipiravir, which shows a novel anti-influenza mechanism acting as RNA polymerase inhibitor, has been developing. These drugs are expected to improve the prognosis of severe cases caused by not only seasonal influenza but pandemic influenza A (H1N1) 2009 virus and H5N1 avian influenza, and also treat oseltamivir-resistant influenza effectively.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Akira Watanabe
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Iain StephensonManish Pareek
Nihon rinsho. Japanese journal of clinical medicine
Daisuke YoshiokaJun-Ichi Kadota
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jaime E HernandezeIND Peramivir Investigators
© 2021 Meta ULC. All rights reserved